GlaxoSmithKline S.A.E. (BIOC) Share Price — EGX

EGP 289.1-5.21%Technicals: Sell

GlaxoSmithKline S.A.E. (BIOC) trades on the Egyptian Exchange (EGX) in the Distribution Services sector. Last updated 10 Sept 2026, 21:08 (Cairo time). EGX sector classification: Health Care & Pharmaceuticals.

What is GlaxoSmithKline S.A.E.’s share price today? BIOC last traded at EGP 289.1 (-5.21% on the day), for a market value of EGP 25.47 billion and a dividend yield of 0.33%. Its 52-week range is EGP 58.03 to 550.

BIOC price performance

1W
-10.5%
1M
-44.5%
3M
+303.6%
6M
+367.1%
YTD
+361.5%
1Y
+345.5%
5Y
+2179.3%

Total return based on EGX closing prices. Past performance does not indicate future results.

About GlaxoSmithKline S.A.E.

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals.The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt.GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

Industry:
Pharmaceutical Preparations
Employees:
800
ISIN:
EGS38171C012
Website:
gsk.com

BIOC key statistics

Last price
EGP 289.1
Previous close
EGP 305
Day change
-5.21%
52-week range
EGP 58.03 – 550
Volume
195,718
Shares outstanding
83.51M
Free float
2.91%
Market cap
EGP 25.47B
Dividend yield
0.33%
Beta (1Y)
0.22
50-day MA
EGP 282.64
200-day MA
EGP 119.64
RSI (14)
39.89

Data as of 10 Sept 2026, 21:08 (Cairo time). Source: Egyptian Exchange via TradingView; financial statements via Yahoo Finance. Prices refresh every 15 minutes during EGX trading hours (Sun–Thu).

Key terms behind the BIOC figures

Market Capitalization
Market capitalization is the total market value of a company’s outstanding shares, calculated as the share price multiplied by the number of issued shares. It is the standard measure used to rank the size of listed companies and to weight them in indices such as the EGX 30. Market cap changes continuously as the share price moves.
Price-to-Earnings (P/E) Ratio
The price-to-earnings ratio divides a company’s share price by its earnings per share, showing how many pounds investors pay for each pound of annual profit. It is one of the most widely used valuation multiples for comparing listed companies within the same sector. A trailing P/E uses reported earnings, while a forward P/E uses forecast earnings.
Price-to-Book (P/B) Ratio
The price-to-book ratio compares a company’s share price with its book value per share, which is shareholders’ equity divided by the number of shares. A ratio of 1 means the stock trades at exactly its accounting net worth. The multiple is used widely for valuing banks and other asset-heavy businesses on the EGX.
Dividend Yield
Dividend yield is the annual cash dividend per share expressed as a percentage of the current share price. It measures the income a shareholder receives from distributions relative to the market price of the stock. Because the calculation uses the market price, the yield rises when the price falls and falls when the price rises, assuming the dividend is unchanged.

Frequently asked questions

What is GlaxoSmithKline S.A.E. (BIOC) share price today?
GlaxoSmithKline S.A.E. last traded at EGP 289.1 on the Egyptian Exchange (as of 10 Sept 2026, 21:08, Cairo time). Prices update every 15 minutes during EGX trading hours.
What is BIOC's market capitalization?
GlaxoSmithKline S.A.E. has a market capitalization of about EGP 25.47B.
Does BIOC pay dividends?
Yes — GlaxoSmithKline S.A.E. has a trailing dividend yield of 0.33% (EGP 0.5 per share).
What sector is GlaxoSmithKline S.A.E. in?
GlaxoSmithKline S.A.E. is listed on the Egyptian Exchange (EGX) in the Distribution Services sector.
Where can I track BIOC?
This Starta Markets page shows GlaxoSmithKline S.A.E.'s live EGX quote, key statistics, financial statements, dividends, technicals and news — or ask the Starta AI analyst about BIOC in Arabic or English.